Skip to main content

Crandell Keith's Form 4 filing

Boundless Bio, Inc. (BOLD) · filed Jul 6, 2026

Accession no.
0001012975-26-000622
Filed
Jul 6, 2026, 5:44 PM ET
Trade date
Jul 1, 2026
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $39.8K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Crandell KeithCIK 000121903910% Owner
Nelsen RobertCIK 000121904210% Owner
Bybee ClintonCIK 000121904310% Owner
Gillis StevenCIK 000122959210% Owner
Burow KristinaCIK 000156924810% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2026Common StockMOption exerciseAcquired+16,000$1.03+$16,48016,000IndirectDuplicate filing
Jul 1, 2026Common StockSSaleDisposed−16,000$2.49−$39,8400IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 1, 2026Common StockMOption exerciseDisposed−16,000$0.00$00IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Remarks

This Form 4 is one of two reports relating to the same transaction being filed jointly by ARCH IX, AVP IX LP, ARCH IX Overage, AVP IX Overage LP, AVP IX LLC, ARCH X Overage, AVP X Overage LP, AVP X LLC, Robert Nelsen, Keith Crandell, Kristina Burow, Steve Gillis and Clint Bybee.

Read the full filing on SEC EDGAR (opens in a new tab)